Neurology Today in 5 – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Neurology Today in 5

American Academy of Neurology

Health & Fitness

Frequency: 1 episode/15d. Total Eps: 99

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇫🇷 France - medicine
03/05/2026
#98
🇫🇷 France - medicine
02/05/2026
#82
🇫🇷 France - medicine
01/05/2026
#62
🇫🇷 France - medicine
30/04/2026
#28

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://www.vyvgarthcp.com/
4 shares
https://www.vyvgarthcp.com
2 shares
https://nam04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.vyvgarthcp.com%2F&data=05%7C01%7CFay.Ellis%40wolterskluwer.com%7Ce3d76a16f6f844f5bfb808db51654be1%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638193267730685347%7CUnknown%7CTWFpbGZsb3d8

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 43%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

Thursday, December 19, 2024 • Duration 05:20

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.

Read moreCollapse

3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

Thursday, December 5, 2024 • Duration 05:02

In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

Read moreCollapse

Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

Thursday, July 18, 2024 • Duration 05:17

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.

Read moreCollapse

Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology

Thursday, July 4, 2024 • Duration 05:10

In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.

Read moreCollapse

When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.

Thursday, June 20, 2024 • Duration 04:45

In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Read moreCollapse

Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics

Thursday, June 6, 2024 • Duration 05:14

In this week’s podcast, Neurology Today’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.

This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Read moreCollapse

Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers

Thursday, May 16, 2024 • Duration 04:54

In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.

Read moreCollapse

Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies

Thursday, May 2, 2024 • Duration 04:48

Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

Read moreCollapse

ME/CFS and long COVID; negative outcomes for ALS drug; donanemab

Thursday, April 18, 2024 • Duration 04:31

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.

Read moreCollapse

BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine

Thursday, April 4, 2024 • Duration 04:24

Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.

Read moreCollapse

Neurology Today in 5 – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Apple Podcasts

Related Shows Based on Content Similarities

Spotify

Neurology Today in 5 – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

Other4

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Apple Podcasts

Related Shows Based on Content Similarities

Other4

Spotify